Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Efficacy Objectives • To investigate the relationship between nocturia, sleep, and daytime performance • To investigate the efficacy of desmopressin orally disintegrating tablets (50 µg in men and 25 µg in women) versus placebo for treatment of patients with nocturia with respect to nocturia, sleep, and daytime performance. Safety Objective • To confirm the safety of desmopressin orally disintegrating tablets (50 µg in men and 25 µg in women) in the treatment of nocturia.
Critère d'inclusion
- Nocturia